Budecort Inhaler 200 MD 100 mcg Cipla
€27.00
Buy Budecort Inhaler 200 MD 100 mcg Cipla at the best price, reasons to buy here
Budecort Inhaler 200 MD 100 mcg, manufactured by Cipla, is a widely recognized corticosteroid used primarily for the management of asthma and chronic obstructive pulmonary disease (COPD). For those looking to enhance their respiratory function and athletic performance, acquiring this inhaler at the best price is paramount. We offer competitive pricing alongside various promotions that ensure you receive the best value for your purchase. Additionally, our commitment to customer service ensures a smooth buying experience, making it simple and convenient for athletes and health-conscious individuals to obtain this essential medication.
General characteristics, composition and activity
Budecort Inhaler contains 200 micrograms of Budesonide, a potent anti-inflammatory agent. It is available in a metered-dose inhaler form, allowing for precise delivery directly into the lungs. The inhaler’s formulation is designed to minimize systemic side effects while maximizing localized therapeutic effects. Budesonide acts primarily on the airways, reducing inflammation and improving airflow. Its property as a corticosteroid makes it effective in controlling and preventing respiratory symptoms such as wheezing, shortness of breath, and coughing, particularly during intense physical exertion or exercise.
Mechanism of action, biological effect
Budesonide works through several biological pathways to exert its therapeutic effects. It binds to specific corticosteroid receptors in airway tissues, leading to a cascade of anti-inflammatory processes. This mechanism involves:
- Inhibition of inflammatory cell migration and activation.
- Reduction of inflammatory mediators such as cytokines and leukotrienes.
- Decreased mucus production, leading to improved airflow.
- Enhanced responsiveness of beta-adrenergic receptors, which contributes to bronchodilation.
These combined actions not only help to alleviate existing symptoms but also play a crucial role in preventing future exacerbations, thus improving overall lung function and capacity. This is particularly beneficial for athletes whose performance may be hindered by respiratory conditions.
Effects on performance, proven results
The positive effects of Budecort Inhaler on athletic performance have been documented in various studies. Athletes suffering from exercise-induced bronchoconstriction may experience significant improvement in their training and competition due to enhanced lung function. Budesonide helps maintain open airways, thereby increasing oxygen uptake and delivery to muscles. Studies show that athletes using Budecort reported reduced incidences of wheezing and soreness during exertion, resulting in prolonged periods of exercise and improved stamina.
Research also indicates that Budesonide can facilitate faster recovery times post-exercise, allowing athletes to train more effectively and consistently. As a result, many competitive athletes incorporate Budecort into their regimen, enabling them to achieve peak performance levels while managing any underlying respiratory conditions.
Safety and contraindications, recommendations
While Budecort is effective for many, it is essential to acknowledge its safety profile and potential contraindications. Common side effects may include throat irritation, hoarseness, or a dry mouth. However, serious side effects are rare when the medication is used as directed. It is crucial for users to be aware of the following recommendations:
- Consult with a healthcare professional prior to starting Budecort, especially if you have existing health conditions.
- Use the inhaler as prescribed, ensuring proper technique to maximize its benefits.
- Monitor for any signs of adverse effects or worsening symptoms and report them to your doctor.
- Avoid sudden cessation of the drug without consulting your physician, as this may lead to a rebound effect.
In summary, Budecort Inhaler 200 MD 100 mcg Cipla is a valuable tool in managing respiratory conditions and boosting athletic performance. With the right precautions and an informed approach, athletes can utilize this medication to enhance their training and competition experiences while maintaining their health and safety.
| Active substance | Budesonide |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Not specific for standard drug tests |
| Strength | 100mcg |
| Also known as | Budesonidum |
| Blood pressure | Typically no effect on blood pressure |
| Trade name | Pulmicort, Rhinocort |
| Storage conditions | Store in a cool, dry place away from direct sunlight |
| Chemical name | (RS)-11ОІ,16О±,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde |
| Formula | C25H34O6 |
| Substance class | Corticosteroid |
| Main action | Anti-inflammatory |
| Half-life | 2 to 3.6 hours |
| Dosage (medical) | Inhalation (100 to 800 micrograms per day), Oral (9 mg per day), Nasal spray (256 micrograms per day) |
| Dosage (sports) | Not applicable |
| Effects | Reduces inflammation, suppresses immune response |
| Side effects | Oral thrush, hoarseness, cough, headache, nausea, adrenal suppression |
| Use in sports | Not commonly used, except for legitimate asthma treatment |
| Manufacturer | Cipla Ltd. |
| Packing | 1 Inhaler/pack |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |










Reviews
There are no reviews yet.